RBC Sees Upside Potential in Neumora Therapeutics (NMRA)

Neumora Therapeutics, Inc. (NASDAQ:NMRA) is one of the 10 Best New Penny Stocks to Invest In. On December 1, RBC Capital upgraded its rating on Neumora Therapeutics, Inc. (NASDAQ:NMRA) from Sector Perform to Outperform and increased its price target from $4 to $7. This increase in price target reflects the firm’s view that Neumora Therapeutics, Inc. (NASDAQ:NMRA) is expanding its focus beyond neurology. According to RBC Capital, this shift is not fully reflected in the company’s current valuation. RBC Se ...